Wiseman Dermatology Research Inc. - Probity - PPDS

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Psoriasis2 trials

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials

Lead sponsor

• DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company1 trial
• Takeda1 trial

Closed trials

• Completed

  A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

  NCT06108544· Phase 3· Takeda· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis

  NCT05896527· Phase 2· DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company· Source